Results 301 to 310 of about 244,580 (333)

Efficacy and prognosis of allogeneic hematopoietic stem cell transplantation in aggressive NK-cell leukemia: a meta-analysis. [PDF]

Ann Hematol
Cao S, Cao C, Wang S.
europepmc   +1 more source

Late Relapse After Autologous Hematopoietic Stem Cell Transplantation in AQP4-IgG-Positive NMOSD.

JAMA Netw Open
Vorasoot N, Blackburn KM, Nguyen L, Bush ML, Jenkins SM, Jitprapaikulsan J, Fryer JP, Irani SR, Flanagan EP, Pittock SJ.   +9 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Hematopoietic Stem-Cell Transplantation

New England Journal of Medicine, 2006
Hematopoietic stem-cell transplantation, which is used to treat both malignant and nonmalignant conditions, was first conceived more than 50 years ago, but problems associated with transplanting a nonsolid organ and modulating the immune response had to be solved before the procedure could be used clinically.
Uptal D. Patel, Matthew J Ellis
openaire   +5 more sources

Hematopoietic Stem Cell Transplantation

Hospital Practice, 1993
The isolation, purification, and in vitro expansion of the hematopoietic stem cell have allowed pretransplant immunologic and genetic manipulation. As a result, rapid allogeneic or autologous hematologic reconstitution with minimal graft-versus-host disease is possible in patients receiving high-dose chemotherapy.
Sundar Jagannath, Guido Tricot, Bart Barlogie   +2 more
openaire   +3 more sources

Hematopoietic Stem Cell Transplantation in Thalassemia

Hematology/Oncology Clinics of North America, 2018
Although recent advances in gene therapy are expected to increase the chance of disease cure in thalassemia major, at present hematopoietic stem cell transplantation (HSCT) remains the only consolidated curative approach for this disorder. The widest experience has been obtained in the HLA-matched family donor (MFD) setting, with probabilities of ...
Strocchio L., Locatelli F.
openaire   +5 more sources

Hematopoietic Stem Cell Transplantation

2003
Over the last half-century, hematopoietic cell transplantation has evolved from an idea to a well-established therapy used in the treatment of tens of thousands of individuals annually. This evolution is the product of laboratory-based investigations, studies using animal models, and especially clinical trials involving human subjects.
Helen E. Heslop, Vilmarie Rodriguez
openaire   +4 more sources

Hematopoietic Stem Cell Transplantation for Thalassemia

Current Stem Cell Research & Therapy, 2009
Hematopoietic stem cell transplantation (HSCT) represents the only cure for patients with thalassemia. At present HSCT in younger patients from an HLA- matched sibling donor offers 80% to 87% probability of cure according to risk classes. However, results HSCT in adult patients continue to be inferior due to advanced of disease.
Guido Lucarelli, Javid Gaziev
openaire   +3 more sources

Hematopoietic Stem Cell Transplantation

2020
Principles and Overview of Allogeneic Hematopoietic Stem Cell Transplantation.- The Principles and Overview of Autologous Hematopoietic Stem Cell Transplantation.- Natural Killer Cell Activity and Killer Immunoglobulin-Like Receptors in Hematopoietic Stem Cell Transplantation.- Advancement and Clinical Implications of HLA Typing in Allogeneic ...
Annie Im, Steven Z. Pavletic
openaire   +2 more sources